Pfizer announced that its vaccine is 95 percent effective. In addition, the developer announced the availability of data on the safety of the drug, writes Mirror.
The vaccine efficacy was the same for all age and ethnic demographic groups. No serious side effects were reported. The company intends to apply for registration in a few days, the newspaper writes.
/OSINT/media/social.